Hypnosis and MEOPA in Regional Painful Syndrome Complex

Combined Therapy of Hypnosis Kinesitherapy and MEOPA in Patients With Regional Painful Syndrome Complex

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03260361

Acronym

ProHKM-SDRC

Enrollment

Registered

2017-08-24

Start date

2017-09-06

Completion date

2022-12-07

Last updated

2023-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Algodystrophy of Hand

Brief summary

Relation between hypnosis and MEOPA on algodystrophy.

Interventions

OTHERHypnosis, kinesitherapy, MEOPA

classical intervention

OTHERUsual practice

Usual practice with treatments and physio

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Regional Painful Syndrome Complex

Exclusion criteria

* deaf people

Design outcomes

Primary

Measure	Time frame	Description
Pain intensity measure using visual analogical ladder (EVA)	3 weeks	pain intensity is determined by patient himself on a visual analogical ladder created by Huskisson

Secondary

Measure	Time frame	Description
QDSA ( Saint Antoine Pain Questions)	3 weeks	description of the type of pain
SF36 (Short Form (36) Health Survey)	3 weeks	quality of life appreciation
HADs	3 weeks	Hospital Anxiety and Depression Scale

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026